Chris J J Mulder
Overview
Explore the profile of Chris J J Mulder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
229
Citations
3815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bayoumy A, Mulder C, de Boer N, Derijks L, Yang J, Schmiegelow K
Pediatr Blood Cancer
. 2024 Nov;
72(2):e31464.
PMID: 39616415
No abstract available.
2.
Agarwal S, Prasad S, Agarwal A, Raja Ali R, Leffler D, Green P, et al.
J Gastroenterol Hepatol
. 2024 Nov;
40(1):142-152.
PMID: 39528309
Background And Aim: Celiac disease (CeD) is increasingly diagnosed but significant disparities exist in awareness, practices, resources, and legislation worldwide. We conducted a global online survey with CeD experts to...
3.
van Rossen T, van Beurden Y, Bogaards J, Budding A, Mulder C, Vandenbroucke-Grauls C
BMC Infect Dis
. 2024 Jul;
24(1):687.
PMID: 38987677
Introduction: Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhoea. Fidaxomicin and fecal microbiota transplantation (FMT) are effective, but expensive therapies to treat recurrent CDI (reCDI). Our...
4.
Bayoumy A, Mulder C, Ansari A, Barclay M, Florin T, Kiszka-Kanowitz M, et al.
Indian J Gastroenterol
. 2024 Feb;
43(1):36-47.
PMID: 38383877
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that encompasses two major conditions: Crohn's disease (CD) and ulcerative colitis (UC). Historically, IBD has been primarily...
5.
Crouwel F, Bayoumy A, Mulder C, Peters J, Boekema P, Derijks L, et al.
Inflamm Bowel Dis
. 2023 Sep;
30(9):1492-1499.
PMID: 37658804
Background: Currently thioguanine is solely used as treatment for inflammatory bowel disease after azathioprine and/or mercaptopurine failure. This study aimed to determine the safety, effectiveness, and 12-month drug survival of...
6.
Mulder C, Elli L, Lebwohl B, Makharia G, Rostami K, Rubio-Tapia A, et al.
Nutrients
. 2023 Jul;
15(9).
PMID: 37432208
For patients with celiac disease (CeD), a lifelong gluten-free diet is not a voluntary lifestyle choice-it is a necessity. The key end points in clinical follow-up are symptom resolution, the...
7.
Tahiri M, Goh K, Abbas Z, Epstein D, Min-Hu C, Mulder C, et al.
J Clin Gastroenterol
. 2023 Jul;
57(7):643-650.
PMID: 37428083
No abstract available.
8.
de Boer N, Simsek M, Meijer B, Neurath M, van Bodegraven A, Mulder C
Gut
. 2023 Jun;
72(10):1985-1991.
PMID: 37380330
Drug rediscovery refers to the principle of using 'old' drugs outside the indications mentioned in the summary of product characteristics. In the past decades, several drugs were rediscovered in a...
9.
Simsek M, Schepers F, Kaplan S, van Asseldonk D, van Boeckel P, Boekema P, et al.
J Crohns Colitis
. 2023 Jan;
17(6):933-942.
PMID: 36702552
Background And Aims: Thioguanine is a well-tolerated and effective therapy for inflammatory bowel disease [IBD] patients. Prospective effectiveness data are needed to substantiate the role of thioguanine as a maintenance...
10.
Crouwel F, Simsek M, de Boer M, Mulder C, van Andel E, Creemers R, et al.
J Crohns Colitis
. 2022 Dec;
17(5):738-745.
PMID: 36521000
Background: Safety of thioguanine in pregnant patients with inflammatory bowel disease [IBD] is sparsely recorded. This study was aimed to document the safety of thioguanine during pregnancy and birth. Methods:...